Psychiatr. praxi. 2022;23(3):150-152 | DOI: 10.36290/psy.2022.030

Sleep disorders in affective disorders

doc. MUDr. Dana Končelíková, Ph.D.
Klinika psychiatrie FN Olomouc

Sleep disorders as a symptom can accompany a variety of conditions, whether mental or physical. They do not always mean illness and at a certain stage of life almost every person has struggled with it. Sleep disturbances, both in terms of shortening, prolonging or changing quality, are a common symptom of mood disorders. The fact that chronobiological treatment leads to mood swings also adds to the interrelationship. Insomnia is also considered a significant risk factor for the development or recurrence of depression, as well as being examined as a predictor of response to treatment. The following article provides a brief overview of the issue of sleep disorders in selected affective disorders.

Keywords: affective disorders, insomnia, hypersomnia, therapy, risk factor, relapse.

Accepted: October 11, 2022; Published: October 25, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Končelíková D. Sleep disorders in affective disorders. Psychiatr. praxi. 2022;23(3):150-152. doi: 10.36290/psy.2022.030.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Grewal RG, Doghramji K. Epidemiology of insomnia. In Clinical handbook of insomnia: Springer, Cham.; 2017. 13-25. Go to original source...
    2. Illnerová H, Sumová A. Vnitřní časový systém. Interní Med. pro praxi. 2018;10(7):350-352.
    3. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues in clinical neuroscience; 2022.
    4. Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biological psychiatry; 1976;11(2):159-174. Go to PubMed...
    5. Thase ME, Kupfer DJ, Spiker DG. Electroencephalographic sleep in secondary depression: a revisit. Biological psychiatry; 1984.
    6. Baglioni C, Nanovska S, Regen W, et al. Sleep and mental disorders: A meta­‑analysis of polysomnographic research. Psychological bulletin. 2016;142(9):969. Go to original source... Go to PubMed...
    7. Pillai V, Kalmbach DA, Ciesla JA. A meta­‑analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biological psychiatry. 2011;70(10): 912-919. Go to original source... Go to PubMed...
    8. Mendlewicz J. Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. The World Journal of Biological Psychiatry. 2009;10(4):269-275. Go to original source... Go to PubMed...
    9. Berger M, Reimann D. REM sleep in depression-an overview. Journal of sleep research. 1993;2(4):211-223. Go to original source... Go to PubMed...
    10. Salvatore P, Indic P, Murray G, et al. Biological rhythms and mood disorders. Dialogues in clinical neuroscience. 2012;14(4):369. Go to original source... Go to PubMed...
    11. Lee A, Myung SK, Cho JJ, et al. Night shift work and risk of depression: meta­‑analysis of observational studies. Journal of Korean Medical Science. 2017;32(7): 1091-1096. Go to original source... Go to PubMed...
    12. Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. The American journal of psychiatry; 1995. Go to PubMed...
    13. Sakurai H, Suzuki T, Yoshimura K, et al. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology (Berl). 2017;234:2453-2461. Go to original source... Go to PubMed...
    14. Dauvilliers Y, Lopez R, Ohayon M, et al. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC medicine. 2013;11(1):1-9. Go to original source... Go to PubMed...
    15. Steinan MK, Scott J, Lagerberg TV, et al. Sleep problems in bipolar disorders: more than just insomnia. Acta Psychiatr. Scand. 2016;133:368-377. Go to original source... Go to PubMed...
    16. Rajkumar RP. Bipolar disorder, COVID-19, and the risk of relapse. Bipolar Disorders; 2020. Go to original source...
    17. Wichniak A, Wierzbicka A, Jernajczyk W. Sleep and antidepressant treatment. Current Pharmaceutical Design. 2012;18(36):5802-5817. Go to original source... Go to PubMed...
    18. Palagini L, Cipollone G, Masci I, et al. Insomnia symptoms predict emotional dysregulation, impulsivity and suicidality in depressive bipolar II patients with mixed features. Comprehensive psychiatry. 2019;89:46-51. Go to original source... Go to PubMed...
    19. Kanady JC, Soehner AM, Klein AB, et al. The association between insomnia­‑related sleep disruptions and cognitive dysfunction during the inter­‑episode phase of bipolar disorder. Journal of psychiatric research. 2017;88:80-88. Go to original source... Go to PubMed...
    20. Murru A, Guiso G, Barbuti M, et al. The implications of hypersomnia in the context of major depression: results from a large, international, observational study. European Neuropsychopharmacology. 2019;29(4):471-481. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.